DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.

作者: Manuel Rieber , Mary Strasberg Rieber

DOI: 10.1002/IJC.24512

关键词: CarcinogenesisSignal transductionCadherinGene mutationCancer researchEpidermal growth factor receptorTransactivationBiologyMutantTumor suppressor gene

摘要: One of the hallmarks carcinomas is epithelial disorganization, linked to overexpression matrix metalloproteases (MMP) like MMP-9, loss intercellular E-cadherin and activation epidermal growth receptor (EGFR/erbB1). Since p53 tumor suppressor pathway inactivated in most human cancers due gene mutations or defective wt signaling, we now investigated breast carcinoma MCF-7 cells, whether single treatment with transactivation pharmacological inhibitor pifithrin-α, transient siRNA interference stable insertion a dominant-negative (DN) R175H mutant increase: (i) EGFR/erbB1 activation, (ii) MMP-9 expression (iii) surface E-cadherin. Transient abrogation function increased phosphorylation expression. However, all these effects were much more pronounced cells stably transduced dominant negative–Arg-175His (DN-R175H p53), which also showed cytoarchitecture extensive downregulation. Collectively, results support notion that DN-R175H exerts gain oncogenic by promoting disruption contacts proliferation signals. Our data suggests shape control are unequally affected depending on how impaired partial full activity lost. © 2009 UICC

参考文章(42)
Roy S. Herbst, Amir Onn, John Mendelsohn, The Role of Growth Factor Signaling in Malignancy Cancer Treatment and Research. ,vol. 115, pp. 19- 72 ,(2004) , 10.1007/0-306-48158-8_2
Takeshi Itoh, Masatoshi Tanioka, Hidetoshi Matsuda, Hirofumi Nishimoto, Takayuki Yoshioka, Ryuji Suzuki, Masahiro Uehira, Experimental metastasis is suppressed in MMP-9-deficient mice. Clinical & Experimental Metastasis. ,vol. 17, pp. 177- 181 ,(1999) , 10.1023/A:1006603723759
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
Shawn M. Ellerbroek, Janel K. Warmka, Elizabeth V Wattenberg, M. Sharon Stack, Mario Benavidez, Jennifer M. Halbleib, Laurie G. Hudson, Laurie G. Hudson, Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Research. ,vol. 61, pp. 1855- 1861 ,(2001)
Teruaki Kobayashi, Koji Hashimoto, Hidenobu Okumura, Hideo Asada, Kunihiko Yoshikawa, Endogenous EGF-family growth factors are necessary for the progression from the G1 to S phase in human keratinocytes Journal of Investigative Dermatology. ,vol. 111, pp. 616- 620 ,(1998) , 10.1046/J.1523-1747.1998.00331.X
Mary Strasberg Rieber, Atilio Anzellotti, Roberto A. Sánchez-Delgado, Manuel Rieber, Tumor apoptosis induced by ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor. International Journal of Cancer. ,vol. 112, pp. 376- 384 ,(2004) , 10.1002/IJC.20415
Gilles Gadéa, Laure Lapasset, Cécile Gauthier‐Rouvière, Pierre Roux, Regulation of Cdc42-mediated morphological effects: a novel function for p53 The EMBO Journal. ,vol. 21, pp. 2373- 2382 ,(2002) , 10.1093/EMBOJ/21.10.2373
Kyung Sik Yoon, Min Cheol Lee, Sam Suk Kang, Jae Hyoo Kim, Shin Jung, Yoon Ji Kim, Jae Hyuk Lee, Kyu Yoon Ahn, Ji Shin Lee, Jong Yoon Cheon, p53 mutation and epidermal growth factor receptor overexpression in glioblastoma. Journal of Korean Medical Science. ,vol. 16, pp. 481- 488 ,(2001) , 10.3346/JKMS.2001.16.4.481
Shin Takahashi, Takuya Moriya, Takanori Ishida, Hiroyuki Shibata, Hironobu Sasano, Noriaki Ohuchi, Chikashi Ishioka, None, Prediction of breast cancer prognosis by gene expression profile of TP53 status Cancer Science. ,vol. 99, pp. 324- 332 ,(2008) , 10.1111/J.1349-7006.2007.00691.X
Ida R.K. Bukholm, Geir Bukholm, Jahn M. Nesland, Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. International Journal of Cancer. ,vol. 93, pp. 283- 287 ,(2001) , 10.1002/IJC.1311